Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 11, 2003

View Archived Issues

A high dose of ximelagatran better than warfarin in preventing DVT after total knee replacement

Cognitive and functional improvements associated with donepezil in vascular dementia

Improved quality of life seen in SLE patients treated with LJP-394

Good cardiovascular safety profile described for ospemifene in postmenopausal women

New inhibitors of VLA-4-mediated cell adhesion developed at Toray

Durable antiviral response induced by tipranavir in heavily pretreated HIV patients

Antiviral activity and pharmacokinetics of SPD-754 in HIV infection

Novel histamine H1 antagonists under study at Almirall Prodesfarma

Pfizer patent covers new NS5B inhibitors with potential in HCV infection

BMS researchers present new protein kinase inhibitors for proliferative and inflammatory disorders

New ErbB kinase inhibitors, their preparation and use revealed in AstraZeneca patent

Ajinomoto presents novel benzodiazepine-based factor Xa inhibitors

Banyu team identifies new glucokinase activators

Indian scientists claim new antibacterial oxazolidinones in recent patent

CAP delivery system extends duration of insulin action in preclinical study

Lysostaphin eradicates MRSA biofilms on artificial surfaces

Hybrigenics and Servier sign new drug discovery agreements

Lexicon moves into ophthalmology

Maxim seeks European approval for Ceplene treatment

Enrollment under way for phase IIb obesity study of AOD-9604

Chiron grants Vertex HCV license

Phase I trial commences for Oxycyte

Specific VRAC inhibitor with antiarrhythmic effects presented in Orlando

Inhibition of malonyl-CoA decarboxylase modulates fatty acid oxidation in rat hearts

LXR agonist ATI-829 increases brain apo E in vitro and in vivo

AR-10A exhibits a suitable profile for further development as an antiobesity agent

JNJ-17153656, a dual delta/mu opioid receptor agonist for GI disorders

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...